REIMBURSEMENT DOSSIER DEVELOPMENT
Reimbursement Dossiers have become essential tools for informing payers about labeled and unlabeled uses of new drugs and communicating the value story. They are also excellent vehicles for organizing the available clinical and economic evidence to identify both strong messages and data gaps. Our dossier teams of clinicians, health economists and medical writers are skilled at drafting dossiers according to standards published by the Academy for Managed Care Pharmacy (AMCP) and individual national payers.




